Quest Diagnostics Incorporated 

(Public, NYSE:DGX)   Watch this stock   
Find more results for DGX
Mar 22, 2010
Barclays Capital Conference Add to calendar
Mar 1, 2010
RBC Capital Markets Healthcare Conference Add to calendar
Feb 10, 2010
UBS Global Healthcare Services Conference - 9:00AM EST - Add to calendar
Jan 26, 2010
Jefferies Global Healthcare Services Conference - Webcast
Jan 25, 2010
Q4 2009 Earnings Conference Call - Webcast
Jan 25, 2010
Q4 2009 Earnings Release
Dec 4, 2009
The American Society of Hematology Annual Meeting and Exposition
Dec 2, 2009
Piper Jaffray Healthcare Conference - Webcast
Nov 17, 2009
Lazard Capital Healthcare Conference - Webcast
More events from AOL Finance »    

Key stats and ratios

Q4 (Dec '09) 2009
Net profit margin 9.84% 9.80%
Operating margin 17.88% 18.23%
EBITD margin - 21.67%
Return on average assets 8.61% 8.61%
Return on average equity 18.46% 19.23%
Employees 42,800 -

Address

3 Giralda Farms
Madison, NJ 07940
United States - Map
+1-201-3935000 (Phone)
+1-201-4624169 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Quest Diagnostics Incorporated discussed on blogs

Quest Diagnostics Incorporated discussions

  View all discussions »

Description

Quest Diagnostics Incorporated is a provider of diagnostic testing, information and services. The Company offers United States patients and physicians the access to diagnostic testing services through its network of laboratories and Company-owned patient service centers. It is a provider of clinical testing, including gene-based and other esoteric testing, anatomic pathology services, including dermatopathology and testing for drugs-of-abuse, and provider of risk assessment services for the life insurance industry. The Company is also the provider of testing for clinical trials. Its diagnostics products business manufactures and markets diagnostic test kits and point-of-care testing. During the year ended December 31, 2008, the Company’s clinical testing business accounted for greater than 90% of its net revenues, with the balance derived from insurer services, clinical trials testing, diagnostic products and healthcare information technology.

Officers and directors

Surya N. Mohapatra Ph.D.
Chairman of the Board, President, Chief Executive Officer
Age: 59
Bio & Compensation - Reuters
Robert A. Hagemann
Chief Financial Officer, Senior Vice President
Age: 52
Bio & Compensation - Reuters
Michael E. Prevoznik
Senior Vice President, General Counsel
Age: 47
Bio & Compensation - Reuters
Joan E. Miller Ph.D.
Senior Vice President - Pathology and Hospital Services
Age: 54
Bio & Compensation - Reuters
Jon Cohen M.D.
Senior Vice President, Chief Medical Officer
Bio & Compensation - Reuters
Wayne R. Simmons
Vice President - Operations
Age: 53
Bio & Compensation - Reuters
Daniel C. Stanzione
Lead Independent Director
Age: 63
Bio & Compensation - Reuters
Gail R. Wilensky Ph.D.
Director
Age: 66
Bio & Compensation - Reuters
William F. Buehler
Director
Age: 69
Bio & Compensation - Reuters
John B. Ziegler
Director
Age: 63
Bio & Compensation - Reuters